Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi after myocardial infarction: reply
Eur Heart J Cardiovasc Pharmacother
.
2022 Jan 5;8(1):E3.
doi: 10.1093/ehjcvp/pvab074.
Authors
Ronny Alcalai
1
,
Gabby Elbaz-Greener
1
,
David Leibowitz
1
Affiliation
1
Cardiac Care Unit, Mt. Scopus Heart Institute, Hadassah Hebrew University Medical Center, Jerusalem 9124001, Israel.
PMID:
34617568
DOI:
10.1093/ehjcvp/pvab074
No abstract available
Publication types
Letter
Comment
MeSH terms
Anticoagulants / adverse effects
Humans
Myocardial Infarction* / drug therapy
Off-Label Use
Thrombosis* / diagnosis
Thrombosis* / drug therapy
Warfarin / adverse effects
Substances
Anticoagulants
Warfarin